Aligos Therapeutics (ALGS) Prepaid Assets (2019 - 2026)
Aligos Therapeutics' (ALGS) quarterly Prepaid Assets came in at $4.5 million in Q1 2026, down 13.14% YoY from $5.2 million in Q1 2025, and down 7.38% on a QoQ basis from $4.9 million in Q4 2025.
Aligos Therapeutics (ALGS) Prepaid Assets (2019 - 2026) Analysis & Trends
Aligos Therapeutics (ALGS) has 8 years of Prepaid Assets data on file, last reported at $4.5 million in Q1 2026.
- Quarterly Prepaid Assets fell 13.14% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 13.14% YoY) and the FY2025 annual result came in at $4.9 million, down 3.61% from the prior year.
- Prepaid Assets retreated to $4.5 million in Q1 2026, from $4.9 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $10.3 million in Q1 2022 to a low of $3.4 million in Q2 2023.
- A 5-year average of $5.6 million and a median of $5.1 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 75.83% — and 2023, when it sank 59.58%.
- Tracing ALGS's Prepaid Assets over 5 years: stood at $7.6 million in 2022, then sank by 30.16% to $5.3 million in 2023, then declined by 4.11% to $5.1 million in 2024, then slipped by 3.61% to $4.9 million in 2025, then retreated by 7.38% to $4.5 million in 2026.
- The last three Prepaid Assets figures came in at $4.5 million (Q1 2026), $4.9 million (Q4 2025), and $4.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Aligos Therapeutics | 67.38 Mn | 36.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Mn |
| Mar 31, 2026 | 4.55 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 4.23 Mn |
| Jun 30, 2025 | 4.89 Mn |
| Mar 31, 2025 | 5.23 Mn |
| Dec 31, 2024 | 5.09 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 4.96 Mn |
| Mar 31, 2024 | 5.11 Mn |
| Dec 31, 2023 | 5.31 Mn |
| Sep 30, 2023 | 4.14 Mn |
| Jun 30, 2023 | 3.36 Mn |
| Mar 31, 2023 | 5.52 Mn |
| Dec 31, 2022 | 7.60 Mn |
| Sep 30, 2022 | 7.71 Mn |
| Jun 30, 2022 | 8.32 Mn |
| Mar 31, 2022 | 10.30 Mn |
| Dec 31, 2021 | 13.53 Mn |
| Sep 30, 2021 | 5.83 Mn |